Paul Kaulius
Foot Surgery · Trexlertown, PANPI 1669442679
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Organogenesis Inc. at 27.8% of the total. Reporting peaked in 2021 at $230 and has fallen 52.8% since, to $109 in 2025.
Across 8 payments — averaging $112.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$250
- KCI USA, Inc.$125
- Paratek Pharmaceuticals, Inc.$125
- Boston Scientific$109
- Stryker$105
- AstraZeneca$97
- plus $88 from 1 others
What the payments were for
- Food & beverage$898100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 2 | $250 |
| KCI USA, Inc. | 1 | $125 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Boston Scientific | 1 | $109 |
| Stryker | 1 | $105 |
| AstraZeneca | 1 | $97 |
| AbbVie | 1 | $88 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Affinity$125
- ACTIVAC$125
- SNAP$125
- Puraply Antimicrobial$125
- NUZYRA$125
- GENERAL PAIN MANAGEMENT$109
- SONICPIN$105
How this compares
$898 in reported general payments places this provider in the 55th percentile of 67 foot surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 12 | $254 |
| Econazole Nitrate | 11 | $165 |
| Gabapentin | 13 | $146 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Trexlertown
- Joshua ScollBensalem$18K
- Derrico QuattroneJefferson Hills$6K
- Dawn SteinGrove City$5K
- Robert NortonPhiladelphia$4K
- Alyssa FitchLancaster$4K
- Peter LarnedKing Of Prussia$3K
- Nikki MiracleBeaver Falls$3K
- Raymond FritzAllentown$2K
- Pamela GekasBryn Mawr$2K
- David BernsteinWayne$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.